Oral Lecithin and Linoleic Acid in Friedreich’s Ataxia: III. Biochemical Results

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Lecithin and sqfflower oil brought about the same changes in serum LAD activity and kinetics in patients with Friedreich’s Ataxia as in controls when results of this double-blind crossover study were analyzed according to group assignation. According to functional stages, pretrial LAD activity decreased with advancing severity while Km for lipoamide increased. Lecithin and sqfflower oil supplements corrected the elevated Km for lipoamide but produced a further reduction in LAD activity. These changes may have been due to the increased intake of linoleic acid, a precursor of lipoic acid, which is present in high percentage in both lecithin and safflower oil. Results of the biochemical study thus agreed with the clinical data gathered during the course of the one-year trial in suggesting that linoleic acid may well have been the active factor through which biochemical and clinical improvement was previously observed in patients with Friedreich’s Ataxia supplemented with lecithin. © 1982, Canadian Neurological Sciences Federation. All rights reserved.

Cite

CITATION STYLE

APA

Melancon, S. B., Dallaire, L., Potier, M., Cousineau, J., Vanasse, M., Geoffroy, G., … Grignon, B. (1982). Oral Lecithin and Linoleic Acid in Friedreich’s Ataxia: III. Biochemical Results. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 9(2), 165–169. https://doi.org/10.1017/S0317167100043882

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free